The Nose Knows: Sniffing out the Unique Immunological Risk of Alternative Tobacco Products
Am J Respir Cell Mol Biol
.
2022 Apr;66(4):461-464.
doi: 10.1165/rcmb.2021-0368LE.
Authors
Emma Karey
1
,
Jade Hess
1
,
Kayla Farrell
1
,
Meghan E Rebuli
2
,
Jenni A Shearston
1
3
,
Lily Lee
1
4
,
Taylor A Reed
1
5
,
James Eazor
1
,
Alec Edid
1
,
Anuradha Shetty
1
,
Sarah Khan
1
,
Grace Gibbon
6
,
Ilona Jaspers
2
,
Michael Weitzman
1
6
,
Terry Gordon
1
6
Affiliations
1
New York University Grossman School of Medicine New York, New York.
2
University of North Carolina at Chapel Hill Chapel Hill, North Carolina.
3
Columbia University New York, New York.
4
State University of New York Downstate College of Medicine Brooklyn, New York.
5
University of California at Los Angeles Los Angeles, California.
6
New York University College of Global Public Health New York, New York.
PMID:
35361069
PMCID:
PMC8990119
DOI:
10.1165/rcmb.2021-0368LE
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Nose
Tobacco Products* / adverse effects
Grants and funding
NIH/NIEHS T32 ES007324/National Institutes of Health/National Institute of Environmental Health Sciences
P30 ES010126/ES/NIEHS NIH HHS/United States
NIH/NIEHS P30 ES000260/National Institutes of Health/National Institute of Environmental Health Sciences
NIH/NIEHS P30 ES010126/National Institutes of Health/National Institute of Environmental Health Sciences
NIH/NHLBI R01 HL139239/HL/NHLBI NIH HHS/United States
NIH/NIEHS T32 ES007126/National Institutes of Health/National Institute of Environmental Health Sciences
NIH/NIEHS R21 ES026996/National Institutes of Health/National Institute of Environmental Health Sciences
NIH/NHLBI R01 HL139369/HL/NHLBI NIH HHS/United States